ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

Clinical trial NCT07098364 · RECRUITING

Trial details

NCT number: NCT07098364
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Diffuse Large B-Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Recurrent Grade 3b Follicular Lymphoma Recurrent High-Grade B-Cell Lymphoma Recurrent Indolent B-Cell Non-Hodgkin Lymphoma Recurrent Primary Mediastinal Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Refractory Grade 3b Follicular Lymphoma Refractory High-Grade B-Cell Lymphoma Refractory Indolent B-Cell Non-Hodgkin Lymphoma Refractory Primary Mediastinal Large B-Cell Lymphoma

Start date: 2025-12-27
Primary completion: 2030-10-04
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.